THURMAN RANDY H 4
4 · TFF Pharmaceuticals, Inc. · Filed Nov 13, 2020
Insider Transaction Report
Form 4
THURMAN RANDY H
Director
Transactions
- Exercise/Conversion
Common Stock
2020-11-11$2.50/sh+34,504$86,260→ 39,504 total - Sale
Common Stock
2020-11-11$15.91/sh−34,504$548,890→ 5,000 total - Sale
Common Stock
2020-11-13$17.17/sh−5,000$85,865→ 0 total - Exercise/Conversion
Stock Options (Right to Buy)
2020-11-11−34,504→ 124,925 totalExercise: $2.50From: 2020-04-11Exp: 2029-04-11→ Common Stock (34,504 underlying)
Footnotes (2)
- [F1]The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- [F2]23,003 shares of common stock vested on April 11, 2020 and the remainder of shares scheduled to vest at an approximate rate of 5,750 every three months thereafter.